Compare EOG Resources Inc (EOG) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EOG Resources Inc vs Revvity Inc — how do they compare? EOG Resources Inc trades at $148.16 (market cap $77.90B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: EOG Resources Inc is far larger — about 4.6× Revvity Inc's market cap, and EOG Resources Inc pays the higher dividend (2.75%). Which is the better fit depends on your goals — on Pluang, investors hold EOG Resources Inc for 59 Days and Revvity Inc for 12 Days on average.
| EOG | RVTY | |
|---|---|---|
Market Cap | $77.90B | $16.98B |
Volume | 2,930,386 | 1,456,900 |
Sector | Energy | Health |
52-Week High | $153.74 | $157.36 |
52-Week Low | $101.78 | $82.26 |
Typical Hold Time | 59 Days | 12 Days |
Enterprise Value | $81.24B | $19.30B |
Dividend Yield | 2.75% | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $148.51, up 2.98% today, with a bullish technical signal from moving averages and strong analyst support. The company demonstrates robust profitability with a 25.81% net income margin and 22.51% ROE, though revenue declined to $22.58B in 2025. Recent earnings beats and a consensus price target of $164.77 highlight positive momentum, while cash flow trends show significant investing outflows for growth.
The outlook for EOG is favorable given its low P/E of 11.56, consistent dividend payments, and projected 2026 revenue growth to $26.6B. Key risks include oil price volatility and high capital expenditures, but strong institutional ownership and zero sell ratings underscore confidence in its disciplined capital allocation and operational execution.
RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.
The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
